ZyVersa Therapeutics, Inc. (ZVSA) SEC filings
ZVSA SEC filings moved a median of -2.08% by the close. ZVSA SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the ZVSA overview →
75 measured ZVSA SEC filing events.
Where these ZVSA SEC filings landedvs 75 measured ZVSA SEC filing reactions
| Middle 50% of ZVSA SEC filing reactions | -6.48% to +3.70% |
|---|---|
| Median reaction (to close) | -2.08% |
| Measured reactions | 75 |
Point-in-time · zero look-ahead
Half of the 75 ZVSA SEC filing events with a measured close landed between -6.48% and +3.70%; 39% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K ZyVersa Therapeutics, For: Jul 16 | SEC filing · Form 8-K | +0.00% | +21.05% | |
| Form 8-K ZyVersa Therapeutics, For: Jul 08 | SEC filing · Form 8-K | +0.00% | +6.40% | |
| Form 10-Q ZyVersa Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +3.80% | +1.17% | |
| Form 10-K ZyVersa Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +0.00% | -6.98% | |
| Form 8-K ZyVersa Therapeutics, For: Feb 27 | SEC filing · Form 8-K | +0.00% | -3.70% | |
| Form 8-K ZyVersa Therapeutics, For: Dec 02 | SEC filing · Form 8-K | +0.00% | +4.79% | |
| Form 10-Q ZyVersa Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -1.26% | +3.70% | |
| Form 8-K ZyVersa Therapeutics, For: Nov 19 | SEC filing · Form 8-K | -1.26% | +3.70% | |
| Form NT 10-Q ZyVersa Therapeutics, For: Sep 30 | SEC filing · Form NT | +0.00% | +8.68% | |
| Form 8-K ZyVersa Therapeutics, For: Oct 10 | SEC filing · Form 8-K | -7.41% | -9.94% | |
| Form 8-K ZyVersa Therapeutics, For: Sep 14 | SEC filing · Form 8-K | +0.00% | +6.67% | |
| Form 10-Q ZyVersa Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -6.25% | -6.13% | |
| Form EFFECT ZyVersa Therapeutics, | SEC filing · Form EFFECT | +0.83% | +9.64% | |
| Form S-1/A ZyVersa Therapeutics, | SEC filing · Form S-1 | -5.26% | -5.16% | |
| Form 8-K ZyVersa Therapeutics, For: Jul 25 | SEC filing · Form 8-K | -3.19% | -14.72% | |
| Form S-1/A ZyVersa Therapeutics, | SEC filing · Form S-1 | -9.21% | -10.79% | |
| Form 8-K ZyVersa Therapeutics, For: Jul 15 | SEC filing · Form 8-K | -24.90% | -41.45% | |
| Form 8-K ZyVersa Therapeutics, For: Jul 08 | SEC filing · Form 8-K | -2.50% | +1.90% | |
| Form S-1 ZyVersa Therapeutics, | SEC filing · Form S-1 | +0.00% | +7.69% | |
| Form 8-K ZyVersa Therapeutics, For: Jun 24 | SEC filing · Form 8-K | +0.86% | +13.13% | |
| Form 8-K ZyVersa Therapeutics, For: Jun 11 | SEC filing · Form 8-K | +2.90% | -5.48% | |
| Form 8-K ZyVersa Therapeutics, For: May 27 | SEC filing · Form 8-K | -1.62% | +7.41% | |
| Form 10-Q ZyVersa Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +3.69% | +0.00% | |
| Form ARS ZyVersa Therapeutics, For: Dec 31 | SEC filing · Form ARS | -4.21% | -1.40% | |
| Form DEF 14A ZyVersa Therapeutics, For: Apr 17 | SEC filing · Form DEF | -4.21% | -1.40% | |
| Form DEFA14A ZyVersa Therapeutics, | SEC filing · Form DEFA14A | -4.21% | -1.40% | |
| Form EFFECT ZyVersa Therapeutics, | SEC filing · Form EFFECT | +10.48% | -26.54% | |
| Form 8-K ZyVersa Therapeutics, For: Apr 04 | SEC filing · Form 8-K | -1.61% | +104.84% | |
| Form PRE 14A ZyVersa Therapeutics, For: Apr 07 | SEC filing · Form PRE | -1.61% | +104.84% | |
| Form S-3 ZyVersa Therapeutics, | SEC filing · Form S-3 | -1.90% | -4.84% | |
| Form 10-K ZyVersa Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -9.40% | -4.40% | |
| Form 8-K ZyVersa Therapeutics, For: Mar 04 | SEC filing · Form 8-K | +4.62% | -2.14% | |
| Form S-8 ZyVersa Therapeutics, | SEC filing · Form S-8 | +0.00% | -2.08% | |
| Form DEF 14A ZyVersa Therapeutics, For: Jan 17 | SEC filing · Form DEF | +1.41% | +4.22% | |
| Form EFFECT ZyVersa Therapeutics, | SEC filing · Form EFFECT | +0.81% | -7.26% | |
| Form PRE 14A ZyVersa Therapeutics, For: Dec 20 | SEC filing · Form PRE | -0.10% | +3.54% | |
| Form S-3 ZyVersa Therapeutics, | SEC filing · Form S-3 | -0.10% | +3.54% | |
| Form 10-Q ZyVersa Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -1.64% | -7.38% | |
| Form 8-K ZyVersa Therapeutics, For: Nov 14 | SEC filing · Form 8-K | -1.64% | -7.38% | |
| Form 8-K ZyVersa Therapeutics, For: Nov 05 | SEC filing · Form 8-K | -2.69% | -17.20% | |
| Form 8-K ZyVersa Therapeutics, For: Oct 29 | SEC filing · Form 8-K | -2.00% | +0.50% | |
| Form 8-K ZyVersa Therapeutics, For: Sep 16 | SEC filing · Form 8-K | +0.45% | +10.76% | |
| Form EFFECT ZyVersa Therapeutics, | SEC filing · Form EFFECT | — | -4.00% | |
| Form ARS ZyVersa Therapeutics, For: Dec 31 | SEC filing · Form ARS | — | -4.00% | |
| Form DEF 14A ZyVersa Therapeutics, For: Sep 09 | SEC filing · Form DEF | — | -4.00% | |
| Form DEFA14A ZyVersa Therapeutics, | SEC filing · Form DEFA14A | — | -4.00% | |
| Form S-3 ZyVersa Therapeutics, | SEC filing · Form S-3 | +0.00% | +9.51% | |
| Form PRE 14A ZyVersa Therapeutics, For: Aug 30 | SEC filing · Form PRE | +0.05% | -4.29% | |
| Form 10-Q ZyVersa Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -2.28% | -7.17% | |
| Form 8-K ZyVersa Therapeutics, For: Aug 01 | SEC filing · Form 8-K | -2.81% | -3.93% | |
| Form EFFECT ZyVersa Therapeutics, | SEC filing · Form EFFECT | +2.27% | -1.14% | |
| Form POS AM ZyVersa Therapeutics, | SEC filing · Form POS | +0.24% | -2.97% | |
| Form 10-K/A ZyVersa Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +2.50% | -5.18% | |
| Form 10-Q ZyVersa Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +2.50% | -5.18% | |
| Form 8-K ZyVersa Therapeutics, For: Apr 25 | SEC filing · Form 8-K | +2.94% | -8.27% | |
| Form 8-K ZyVersa Therapeutics, For: Apr 17 | SEC filing · Form 8-K | +0.50% | +4.33% | |
| Form DEFA14A ZyVersa Therapeutics, | SEC filing · Form DEFA14A | +1.15% | -1.32% | |
| Form 10-K ZyVersa Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -1.49% | -2.07% | |
| Form DEF 14A ZyVersa Therapeutics, For: Mar 19 | SEC filing · Form DEF | -3.36% | -1.19% | |
| Form 8-K ZyVersa Therapeutics, For: Mar 06 | SEC filing · Form 8-K | -0.79% | -8.86% | |
| Form PRE 14A ZyVersa Therapeutics, For: Mar 08 | SEC filing · Form PRE | -0.79% | -8.86% | |
| Form 8-K ZyVersa Therapeutics, For: Feb 29 | SEC filing · Form 8-K | -2.43% | -6.84% | |
| Form S-8 ZyVersa Therapeutics, | SEC filing · Form S-8 | -1.29% | +0.31% | |
| Form 8-K ZyVersa Therapeutics, For: Dec 22 | SEC filing · Form 8-K | +0.01% | +0.12% | |
| Form 8-K ZyVersa Therapeutics, For: Dec 06 | SEC filing · Form 8-K | +0.54% | -10.48% | |
| Form EFFECT ZyVersa Therapeutics, | SEC filing · Form EFFECT | -2.82% | -7.26% | |
| Form S-1/A ZyVersa Therapeutics, | SEC filing · Form S-1 | -2.82% | -7.26% | |
| Form S-1/A ZyVersa Therapeutics, | SEC filing · Form S-1 | -7.65% | +10.71% | |
| Form 8-K ZyVersa Therapeutics, For: Nov 30 | SEC filing · Form 8-K | -20.72% | -31.29% | |
| Form S-1/A ZyVersa Therapeutics, | SEC filing · Form S-1 | -1.42% | +6.22% | |
| Form 8-K ZyVersa Therapeutics, For: Nov 14 | SEC filing · Form 8-K | -3.09% | +0.25% | |
| Form 10-Q ZyVersa Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +0.12% | -3.26% | |
| Form S-1 ZyVersa Therapeutics, | SEC filing · Form S-1 | +0.00% | +0.35% | |
| Form 8-K ZyVersa Therapeutics, For: Oct 31 | SEC filing · Form 8-K | +9.86% | +8.26% | |
| Form EFFECT ZyVersa Therapeutics, | SEC filing · Form EFFECT | +1.00% | -2.28% |
Keep exploring
More ZVSA: earnings → · analyst actions → · ZVSA overview →